CD4 and lung carcinoma: For example, PX478 significantly reduced HIF-1α levels and inhibited tumor growth in a lung cancer xenograft model, and BAY 87–2243 restored the balance of CD4+ T-cell subsets and reduced the production of the pro-inflammatory cytokines, thus acting as both an immune imbalance regulator and anti-inflammatory (56, 57).